Morris Jessica Edgar Insider Trades

Insider Trading History

Track insider trading activity for Morris Jessica Edgar. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $463k 39,011 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 39,011 shares
$14.29
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $463k 39,012 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 39,012 shares
$14.29
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $348k 29,291 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$236k 29,291 shares
$8.05
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $348k 29,291 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$236k 29,291 shares
$8.05
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Feb 05, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$15 1 shares
$14.98
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $3.77M 317,000 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$373M 317,000 shares
$1,177.60
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $3.77M 317,000 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$373M 317,000 shares
$1,177.60
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $2.47M 207,500 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.03B 207,500 shares
$14,622.02
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $2.47M 207,500 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.03B 207,500 shares
$14,622.02
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $13.1M 1,100,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146B 1,100,000 shares
$132,352.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $6.42M 540,000 shares
Last Trade
Feb 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422B 540,000 shares
$780,800.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $6.42M 540,000 shares
Last Trade
Feb 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422B 540,000 shares
$780,800.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $4.28M 360,000 shares
Last Trade
May 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177B 360,000 shares
$492,800.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $4.28M 360,000 shares
Last Trade
May 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177B 360,000 shares
$492,800.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $285k 24,000 shares
Last Trade
Feb 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.21B 24,000 shares
$258,816.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $285k 24,000 shares
Last Trade
Feb 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.21B 24,000 shares
$258,816.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $343k 28,835 shares
Last Trade
May 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$378B 28,835 shares
$13,120,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $343k 28,835 shares
Last Trade
May 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$378B 28,835 shares
$13,120,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $61.4k 5,170 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.5B 5,170 shares
$12,096,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Operating Officer
Holding Value $61.4k 5,170 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.5B 5,170 shares
$12,096,000.00
$11.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up